Susanna Fischer

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

T Flohr, André Schrauder, Giovanni Cazzaniga et al. · Leukemia · 2008 · 360 citations

Medicine, Hematology, Oncology +15

The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin.

Samia Mankarious, M Lee, Susanna Fischer et al. · PubMed · 1988 · 247 citations

Life Sciences, Clinical Pharmacokinetics, Pharmacokinetics +9

CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

M. Farrington, Laura S. Grosmaire, Shigeaki Nonoyama et al. · Proceedings of the National Academy of Sciences · 1994 · 230 citations · Full text

Life Sciences, Immunology, Pathology +13

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases

Hans D. Ochs, Susanna Fischer, Ralph Wedgwood et al. · The American Journal of Medicine · 1984 · 105 citations

Life Sciences, Immunology, Internal Medicine +7

Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2–harboring clones as main relapse-driving force in childhood ALL

Maria Morak, Andishe Attarbaschi, Susanna Fischer et al. · Blood · 2012 · 57 citations · Full text

Life Sciences, Biology, Molecular Biology +4